{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:12:22Z","timestamp":1762344742640,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA256382"],"award-info":[{"award-number":["R21CA256382"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bmcl.2025.130213","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T11:42:01Z","timestamp":1743421321000},"page":"130213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A small-molecule pretargeting approach for PSMA-targeted conjugates"],"prefix":"10.1016","volume":"122","author":[{"given":"Nooshin","family":"Mesbahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosog","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody D.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford E.","family":"Berkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bmcl.2025.130213_bb0005","first-page":"3893S","article-title":"Molecular advances in pretargeting radioimmunotherapy with bispecific antibodies","volume":"9","author":"Chang","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130213_bb0010","first-page":"139","article-title":"Cancer imaging and therapy with bispecific antibody pretargeting","volume":"31","author":"Goldenberg","year":"2007","journal-title":"Ultrastruct Pathol"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130213_bb0015","first-page":"2453","article-title":"New insights into the pretargeting approach to image and treat tumours","volume":"45","author":"Rossin","year":"2016","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2025.130213_bb0020","first-page":"9","article-title":"Therapeutic applications of pretargeting","volume":"11","author":"Goodwin","year":"2019","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130213_bb0025","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1158\/1535-7163.MCT-11-0191","article-title":"In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen","volume":"10","author":"Wang","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"10.1016\/j.bmcl.2025.130213_bb0030","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1158\/0008-5472.CAN-14-0594","article-title":"Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer","volume":"74","author":"L\u00fctje","year":"2014","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130213_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/anse.202200013","article-title":"Recent advances in Pretargeted imaging of tumors in vivo","volume":"2","author":"Huang","year":"2022","journal-title":"Analysis Sensing"},{"key":"10.1016\/j.bmcl.2025.130213_bb0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3389\/fonc.2020.01131","article-title":"Theranostic Pretargeting drug delivery and imaging platforms in Cancer precision medicine","volume":"10","author":"Hapuarachchige","year":"2020","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130213_bb0045","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1039\/D3TB02543H","article-title":"Pretargeted radiotherapy and synergistic treatment of metastatic, castration-resistant prostate cancer using cross-linked, PSMA-targeted lipoic acid nanoparticles","volume":"12","author":"Dai","year":"2024","journal-title":"J Mater Chem B"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130213_bb0050","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.7150\/thno.96403","article-title":"Actinium-225 targeted alpha particle therapy for prostate cancer","volume":"14","author":"Bidkar","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130213_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12951-024-02312-y","article-title":"A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy","volume":"22","author":"Yang","year":"2024","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130213_bb0060","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2967\/jnumed.109.066589","article-title":"Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer","volume":"50","author":"Lapi","year":"2009","journal-title":"J Nucl Med: Off Publ Soc Nucl Med"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130213_bb0065","first-page":"1349","article-title":"Detection of prostate-specific membrane antigen on HUVECs in response to breast tumor-conditioned medium","volume":"38","author":"Liu","year":"2011","journal-title":"Int J Oncol"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130213_bb0070","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1016\/j.bmcl.2011.09.115","article-title":"Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen","volume":"21","author":"Liu","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130213_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2010.04.003","article-title":"Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption","volume":"296","author":"Liu","year":"2010","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130213_bb0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/pros.20909","article-title":"In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen","volume":"69","author":"Liu","year":"2009","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130213_bb0085","first-page":"777","article-title":"Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8\/\u22123 cascade pathway","volume":"36","author":"Liu","year":"2010","journal-title":"Int J Oncol"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130213_bb0090","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/j.bmcl.2010.09.057","article-title":"A targeted low molecular weight near-infrared fluorescent probe for prostate cancer","volume":"20","author":"Liu","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130213_bb0095","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/pros.20753","article-title":"Cell-surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen","volume":"68","author":"Liu","year":"2008","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130213_bb0100","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/pros.21493","article-title":"A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent","volume":"72","author":"Nedrow-Byers","year":"2011","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130213_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.21221","article-title":"Flow cytometric detection of prostate tumor cells using chemoaffinity labels","volume":"71","author":"Wu","year":"2011","journal-title":"Prostate"},{"issue":"24","key":"10.1016\/j.bmcl.2025.130213_bb0110","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1021\/ac202001z","article-title":"High resolution time-of-flight mass analysis of the entire range of intact singly-charged proteins","volume":"83","author":"Lee","year":"2011","journal-title":"Anal Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130213_bb0115","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1021\/bc500362n","article-title":"Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancer","volume":"25","author":"Martin","year":"2014","journal-title":"Bioconjug Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130213_bb0120","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.nucmedbio.2015.06.003","article-title":"A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer","volume":"42","author":"Ganguly","year":"2015","journal-title":"Nucl Med Biol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130213_bb0125","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1021\/acs.jmedchem.5b01850","article-title":"Structure-activity relationship of (18)F-labeled Phosphoramidate Peptidomimetic prostate-specific membrane antigen (PSMA)-targeted inhibitor analogues for PET imaging of prostate Cancer","volume":"59","author":"Dannoon","year":"2016","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130213_bb0130","first-page":"938","article-title":"Prostate-specific membrane antigen-targeted turn-on probe for imaging cargo release in prostate cancer cells","volume":"33","author":"Olatunji","year":"2022","journal-title":"Bioconjug Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:06:42Z","timestamp":1762344402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"alternative-id":["S0960894X25001222"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130213","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small-molecule pretargeting approach for PSMA-targeted conjugates","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130213"}}